Literature DB >> 6386844

Bacterial growth and killing in chronic ambulatory peritoneal dialysis fluids.

H A Verbrugh, W F Keane, W E Conroy, P K Peterson.   

Abstract

We determined the ability of Staphylococcus epidermidis, Staphylococcus aureus, and Escherichia coli to survive and grow in peritoneal dialysis fluids from patients undergoing chronic ambulatory peritoneal dialysis. Staphylococci did not survive in commercially available dialysis solutions but grew readily in peritoneal effluents obtained from patients after the dialysis dwell time. The number of CFU doubled 6 and 13 times in 24 h for S. epidermidis and S. aureus, respectively. E. coli grew well in both the pre- and postdialysis peritoneal fluid. Peritoneal macrophages as well as peripheral blood leukocytes inhibited bacterial growth in peritoneal dialysis fluid. However, 10(6) phagocytes per ml were minimally required to obtain a bacteriostatic effect. The addition of serum to peritoneal dialysis fluid increased the antibacterial activity of macrophages and blood leukocytes. The capacity of the aminoglycoside antibiotic tobramycin to reduce bacterial CFU in peritoneal dialysis fluid was only 10% of its bactericidal capacity in standard Mueller-Hinton brush. Peritoneal dialysis fluid had no effect on the antibacterial activity of imipenem.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386844      PMCID: PMC271286          DOI: 10.1128/jcm.20.2.199-203.1984

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Cellular composition of peritoneal effluent: response to bacterial peritonitis.

Authors:  R M Hurley; D Muogbo; G W Wilson; M A Ali
Journal:  Can Med Assoc J       Date:  1977-11-05       Impact factor: 8.262

2.  Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro.

Authors:  A K Duwe; S I Vas; J W Weatherhead
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

3.  Continuous ambulatory peritoneal dialysis: three-year experience at one center.

Authors:  K D Nolph; M Sorkin; J Rubin; D Arfania; B Prowant; L Fruto; D Kennedy
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391

4.  Peritoneal dialysis during peritonitis.

Authors:  J Rubin; S McFarland; E W Hellems; J D Bower
Journal:  Kidney Int       Date:  1981-03       Impact factor: 10.612

5.  Unidirectional absorption of gentamicin from the peritoneum during continuous ambulatory peritoneal dialysis.

Authors:  P Somani; R S Shapiro; H Stockard; J T Higgins
Journal:  Clin Pharmacol Ther       Date:  1982-07       Impact factor: 6.875

6.  Peritonitis during continuous ambulatory peritoneal dialysis.

Authors:  J Rubin; W A Rogers; H M Taylor; E D Everett; B F Prowant; L V Fruto; K D Nolph
Journal:  Ann Intern Med       Date:  1980-01       Impact factor: 25.391

7.  Kinetics of phagocytosis and bacterial killing by human polymorphonuclear leukocytes and monocytes.

Authors:  P K Peterson; J Verhoef; D Schmeling; P G Quie
Journal:  J Infect Dis       Date:  1977-10       Impact factor: 5.226

8.  Effect of cation content of agar on the activity of gentamicin, tobramycin, and amikacin against Pseudomonas aeruginosa.

Authors:  J A Washington; R J Snyder; P C Kohner; C G Wiltse; D M Ilstrup; J T McCall
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

9.  Continuous ambulatory peritoneal dialysis.

Authors:  R P Popovich; J W Moncrief; K D Nolph; A J Ghods; Z J Twardowski; W K Pyle
Journal:  Ann Intern Med       Date:  1978-04       Impact factor: 25.391

10.  Antagonistic effect of calcium in serum on the activity of tobramycin against Pseudomonas.

Authors:  S D Davis; A Iannetta
Journal:  Antimicrob Agents Chemother       Date:  1972-06       Impact factor: 5.191

View more
  16 in total

1.  Cell envelope proteins of Staphylococcus epidermidis grown in vivo in a peritoneal chamber implant.

Authors:  B Modun; P Williams; W J Pike; A Cockayne; J P Arbuthnott; R Finch; S P Denyer
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  In vitro study of bacterial growth in continuous ambulatory peritoneal dialysis fluids.

Authors:  N K Sheth; C A Bartell; D A Roth
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

3.  In vitro antistaphylococcal activity of teicoplanin and ciprofloxacin in peritoneal dialysis effluent.

Authors:  D Guay; R Klicker; T Pence; P Peterson
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

4.  In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid.

Authors:  C Weissauer-Condon; I Engels; F D Daschner
Journal:  Eur J Clin Microbiol       Date:  1987-06       Impact factor: 3.267

5.  Total volume culture technique for the isolation of microorganisms from continuous ambulatory peritoneal dialysis patients with peritonitis.

Authors:  M S Dawson; A M Harford; B K Garner; D A Sica; D M Landwehr; H P Dalton
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

6.  Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.

Authors:  C A Johnson; S W Zimmerman; D P Reitberg; T J Whall; J E Leggett; W A Craig
Journal:  Antimicrob Agents Chemother       Date:  1988-01       Impact factor: 5.191

7.  In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Authors:  D C Halstead; J Guzzo; J A Giardina; A E Geshan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

8.  Functional blocking of Staphylococcus aureus adhesins following growth in ex vivo media.

Authors:  Ruth C Massey; Shobana R Dissanayeke; Brian Cameron; David Ferguson; Timothy J Foster; Sharon J Peacock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Effect of vancomycin hydrochloride on Staphylococcus epidermidis biofilm associated with silicone elastomer.

Authors:  R C Evans; C J Holmes
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

10.  Characterization of cell envelope proteins of Staphylococcus epidermidis cultured in human peritoneal dialysate.

Authors:  D G Smith; M H Wilcox; P Williams; R G Finch; S P Denyer
Journal:  Infect Immun       Date:  1991-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.